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Abstract
Sauna bathing improves heart rate variability (HRV), resting blood pressure (BP),
fasting plasma glucose (FPG) and body composition in patients with chronic heart failure
(CHF) and diabetes, and benefits depressed patients. Sauna bathing elicits similar
physiological responses to exercise, including increases in core temperature, sweating,
heart rate and skin blood flow. Exercise training decreases cardiovascular and metabolic
disease morbidity and mortality rates. Despite these benefits, only 50.9% of Windsor-Essex
County is moderately physically active. Further, reduced aerobic fitness, BP, FPG, body
composition, etc. occur with age. As such, it is of interest to examine whether sauna bathing
as a form of passive heating prevents the onset of cardiovascular and metabolic disease by
improving health markers in middle aged adults. To examine this question, we recruited 5
healthy, sedentary to moderately active middle-aged participants to undergo sauna bathing
5 times per week for 2 weeks. The sauna intervention consisted of a 15 minute dry sauna
exposure at approximately 60°C followed by 30 minutes of covered rest. Resting HR and
BP, HRV, body composition, blood lipids (TC, HDL, LDL, TRG), FPG, hematocrit (HCT) and
state trait anxiety (STAI) were measured at baseline, following two weeks of normal activity
and following two weeks of daily sauna bathing. Tympanic temperature was measured
during each sauna exposure and showed a significant increase following the 15 minute
sauna bath (p<.001). Resting HR, BP, HRV, body composition, STAI, blood lipids, and FPG
were unchanged following two weeks of sauna use (p>.05). HCT increased following two
weeks of sauna use (p<.05). These results suggest that daily dry sauna bathing with a
concomitant 1.9 ± 0.6 °C tympanic temperature increase does not improve markers of
cardiovascular, metabolic and psychological health among generally healthy middle-aged
adults.
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Chapter 1-Literature Review
1.0 The origins of thermal therapy and saunas
Originating in Finland, the sauna bath is now popular worldwide. What was first
described by the Greek historian Herodotus in 440 BC as “three pieces of wood leaning
against each other” with “red-hot stones…in the middle” (Herodotus & Bähr, 1848) has
become common practice in northern Russia, Finland, Norway, and Iceland while similar
customs have been practiced among Eskimo and American Indian tribes of Alaska and
Canada as well as parts of South America (Lopatin, 1960). While the methods of
passively heating the body are different, they all involve raising core temperature for
brief periods. For example, in Central Asia, the Turkish bath involves moving between
warm and hot rooms, followed by immersion in cool water. Heating is also a component
of the Arabian bath (hammam), although warm stone platforms take the place of steam or
dry heat. Unlike these practices, which focus on cleansing the body, kashim baths are
common among Alaskan Eskimos and involve dry heat from fire followed by a brief
period of snow or ice exposure (Lopatin, 1960).
Early sauna bathing was considered a spiritual process, however, the popularity of
the modern sauna is more closely tied to the health and fitness industry. Numerous claims
associate regular sauna use with weight loss, sweating “toxins” out of the body, as well as
greater feelings of well being and relaxation (Biro, Masuda, Kihara, & Tei, 2003;
Cecchini & LoPresti, 2007; Masuda, Nakazato, Kihara, Minagoe, & Tei, 2005). While
evidence of these health effects is limited, more recent literature focuses on the potential
1

cardiovascular benefits of passive heating (Imamura et al., 2001; Kihara et al., 2004,
2009).
1.1 Exercise is a physiological stress
Chronic stress, both physiological and psychological, is associated with a
variety of negative health outcomes (Thoits, 2010). However, chronic physical activity,
involving shifts away from internal homeostatic set points and consequently a stress to
the physiological system, leads to improvements in human physiological functioning and
psychological well-being. The stresses resulting from exercise include increased oxygen
demand, elevated body temperature (Radomski, Cross, & Buguet, 1998) tissue damage
(Powers, 2008) reduced pH (increased acidity) and a host of metabolic stressors such as
increased reactive oxygen and nitrogen species (Powers, 2008) and an increase in
cytokines (Vassilakopoulos et al., 2003) among others. Further, as exercise intensity
and/or duration increases, these stresses are augmented (Fisher-Wellman & Bloomer,
2009). Nonetheless, the beneficial effects of chronic exercise undoubtedly occur because
the body adapts to these stresses. These adaptations include changes in fuel mobilization
(Sherman, 1995), changes in muscle fibre type (Pette & Staron, 2001; Röckl, Witczak, &
Goodyear, 2008), more efficient oxygen extraction (Cooper, Beaver, Cooper, &
Wasserman, 1992), improved vascular control (Higashi et al., 1999; Rowell, 1974) as
well as increased sweat production (Ichinose, Inoue, Hirata, Shamsuddin, & Kondo,
2009; Rowell, 1984). This resistance is conferred through improved cardiorespiratory
fitness, and changes in markers of metabolic and cardiovascular disease. With regular
exercise, reductions in type II diabetes (Sigal, 2006), hypertension (Chobanian et al.,
2003; Gupta & Guptha, 2010), coronary artery disease (CAD) and CAD symptoms
2

(Thompson & Lim, 2003) are observed, and not surprisingly then, so too are reductions
in premature mortality (Blair et al., 1996). Furthermore, exercise enhances psychological
well-being (Taylor, Sallis, & Needle, 1985) and may provide therapeutic benefits for
those with depressive disorders (Babyak et al., 2000). Therefore, exercise as a
physiological stress produces positive health outcomes.
Nonetheless, many individuals do not make physical activity a part of their daily
lives. In Windsor-Essex County, only 50.9% of the population is moderately active or
active (Statistics Canada Health Profile, 2011). The current physical activity
recommendations for adults 18-64 are 150 minutes of moderate to vigorous aerobic
activity each week (Canadian Society for Exercise Physiology, 2012). However,
common reasons that individuals provide for not meeting physical activity requirements
are insufficient time and fatigue (Brownson, Baker, Housemann, Brennan, & Bacak,
2001). Moreover, some negatives associated with exercise are the risk of injury (e.g.
sprains, strains, falls, etc.) and the physical demanding nature of the activity. In contrast,
passive heating represents a cardiovascular strain, but eliminates some of these negatives
and consequently, the role of heat therapy and the subsequent cardioprotective and/or
disease-protective effects may provide a viable alternative to traditional exercise training
and rehabilitation.
1.2 Exposure to heat is a physiological stress
Passive heating stimulates a physiological response similar to that of exercise,
whereby the body must work to resist a shift away from homeostasis and ensure survival.
Chronic exposure to high ambient temperatures without appropriate rest, fluid and
3

electrolyte replacement is detrimental to human health, potentially resulting in heat
illness, heat stroke or death. The physiological stress of extreme temperatures is most
dangerous for young children (due to small body size) and the elderly, who are often
mildly dehydrated or have an underlying condition exacerbated by heat. In an effort to
minimize these events, Environment Canada issues heat alerts and advisories when
Canadian summer temperatures exceed 30°C.
Depending on the severity of heat stress, heat exhaustion or heat stroke may occur.
Sweating, headache, nausea, vomiting, and dizziness characterize heat exhaustion while
symptoms of heat stroke include core temperatures above 40°C and central nervous
system dysfunction (Canadian Centre for Occupational Health and Safety, 2008). Heat
illness has been reported at various sport and exercise events, such as the 2007 Chicago
Marathon. At that event, one fatality and forty-nine hospitalizations were documented
due to high temperatures and humidity (Rousseau, 2007).
To account for the stress of elevated body temperature, cardiovascular adaptations,
many of which are similar to the adaptations observed with exercise, occur. The body
must dissipate heat to prevent the denaturation and dysfunction of proteins vital to
physiological and metabolic processes. To do so, heart rate increases approximately ten
beats per minute for each degree (1°C) of body temperature increase (Clark & Edholm,
1985). This elevation aids the process of evaporative cooling, where increased skin blood
flow couples with eccrine (the major sweat glands found all over the body) sweating to
dissipate heat (Gagnon, 2009). For example, when resting heart rate and oral temperature
were compared to values following an 80°C dry sauna exposure, an approximate 1°C oral
4

temperature increase elicited a heart rate increase from 71± 12 beats per minute to 96 ±
18 beats per minute (Kukkonen-Harjula et al., 1989). Similar heart rate changes have
been observed following an 80°C sauna exposure (Leppäluoto, Tuominen, Väänänen,
Karpakka, & Vuori, 1986).
Heart rate comprises a component of cardiac output (Q), where Q is a function of
heart rate (HR) multiplied by stroke volume (SV), and outlined by the following
equation:
EQ.1

Q (mL/min) = HR (bpm) x SV (mL).

As such, heat stress is accompanied by greater cardiac output. In fact, heat exposure can
increase skin blood flow from 300 mL/min-1 to 7500 mL/min-1, as flow is directed away
from non-essential organs. Furthermore, increased cutaneous flow causes a decrease in
central blood volume, and a 3-5 mmHG reduction in central venous pressure (Minson,
Wladkowski, Cardell, Pawelczyk, & Kenney, 1998). These reductions, coupled with
unchanged or slightly elevated stroke volumes lead to greater myocardial contractility
(Brothers et al., 2009; Rowell, 1984). As stroke volume is not significantly changed
during heat stress, increased cardiac output is the result of elevated HR (Minson et al.,
1998; Wilson et al., 2007) occurring with core temperature elevations of 1°C to 1.5°C
(Fan et al., 2008).
In addition to cardiovascular changes, increased skin blood flow couples with eccrine
sweat production to aid in thermoregulation. When ambient temperatures are greater than
5

skin temperatures, increased skin blood flow permits heat from the blood to combine with
water in sweat to undergo a phase change and form a gas, thus dissipating heat from the
body (Shibasaki & Crandall, 2010). To further aid in thermoregulation, sweat production
occurs. The eccrine sweat response is initiated centrally by the hypothalamus and aids in
evaporative cooling (Morrison & Nakamura, 2011).
Furthermore, as with exercise, the effects of whole body thermal stress are countered
with ventilation changes. As early as 1905, a study of coal mining conditions revealed
the effects of high ambient temperatures on ventilation (Haldane, 1905). Haldane entered
the mines and experienced these effects first hand, and reported “breathing deeper and
more frequent” at an oral temperature of 102.6°F (Haldane, 1905). Later animal work
also demonstrated ventilatory changes during heating using canine carotid bodies
perfused with heated blood (Bernthal, 1939). The carotid bodies are located on the wall
of the left and right common carotid arteries, and, along with the aortic bodies on the wall
of the aortic arch, are sensitive to oxygen, carbon dioxide and pH changes in the blood. It
has also been suggested these bodies are temperature sensitive (Bernthal, 1939; Gallego,
Eyzaguirre, & Monti-Bloch, 1979; Loyola et al., 1991). When change is detected,
ventilation is altered to restore homeostasis. In the case of elevated blood temperature,
ventilation increases to aid in thermoregulation through the exhalation of warm air.
These effects have been observed in humans exposed to hyperthermic conditions, and in
instances when esophageal temperatures increase up to +2°C (Curtis, Walsh, & White,
2007; Fan et al., 2008).
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Heating may also influence oxygen extraction, especially by essential organs (GonzálezAlonso et al., 2004). Given that peripheral blood flow increases during heat stress, it is
crucial for the brain to receive an adequate oxygen supply in order to maintain essential
metabolic processes. Fan et al. (2008) noted that despite changes to peripheral blood
flow, cerebral oxygenation remained unchanged during passive heating. Similarly,
hyperthermic exercise trials elevating core temperature to 39.5 ± 0.2°C result in a seven
percent increase in cerebral oxygen uptake (Nybo, Secher, & Nielsen, 2002). Greater
oxygen extraction contributes to larger arterial-venous oxygen differences ((a-v)O2diff)
and given the intimate nature between oxygen consumption and the cardiovascular
system, can be included in what is known as the Fick equation:
EQ.2

VO2 = Q x (a-v)O2 diff.

This relationship between cardiac output (Q), (a-v)O2 difference and oxygen consumption
(VO2) also exists during exercise as skeletal muscle oxygen consumption increases, and
is important to the understanding of why the cardiovascular system adapts to both
exercise and passive heating.
1.3 Mechanisms of physiological responses to heat
The mechanisms behind these physiological responses to heat are not entirely known,
but it has been shown that as environmental temperature increases, warmth receptors in
the skin are activated (Morrison & Nakamura, 2011). These neurons synapse in the
dorsal horn of the spinal cord and the signal travels to the brain, or more specifically, the
medial preoptic area and median preoptic nucleus of the hypothalamus (Morrison &
Nakamura, 2011). Neurons from these regions inhibit excitatory pathways that drive
7

sympathetic thermoregulatory effectors (pathways), causing a decline in
thermogeneration and an increase in cutaneous vasodilation (Morrison & Nakamura,
2011). The preoptic hypothalamus also increases eccrine sweating, as efferents (i.e.
neuronal output) from this brain centre innervate sweat glands (Shibasaki & Crandall,
2010). Eccrine sweat glands are distributed all over the body, but are highly concentrated
on volar surfaces, such as the palms of the hands and soles of the feet (Henrikson, Kaye,
& Mazurkiewicz, 1997).
The secretory portion of the sweat gland has a coil structure, consists of clear and
dark cells, which contain secretory vacuoles and aquaporins (i.e. cellular membrane
spanning water channels) for fluid excretion, and is located at the dermo-subcutaneous
junction (Munger, Van Tassell, & LaFleur, 2007; Nejsum et al., 2002). The isotonic fluid
(having the same salt concentration as blood) produced in the secretory portion travels
through the duct where it is released onto the skin surface.
Coupled with vasodilation, sweating aids in thermoregulation through evaporative
cooling. Nerve endings on the skin containing Transient Receptor Potential Vanillioid
(TRPV) channels that detect changes in temperature, and this sensory information is sent
to the POAH (preoptic area of the hypothalamus) along with input from central
thermoreceptors in the hypothalamus (Morrison & Nakamura, 2011). Sympathetic
efferents innervating the smooth muscle surrounding arterioles, stimulate relaxation and
consequently dilation to increase blood flow (Shibasaki & Crandall, 2010).
Further, when CO2 crosses the blood-brain-barrier, hydrogen ions (H+) are formed.
Central chemoreceptors are sensitive to changes in [H+], and initiate increased breathing
8

depth and frequency to buffer these byproducts. Curtis et al. (2007) suggested that these
chemoreceptors may also be temperature sensitive, accounting for the alterations in
ventilation during passive heating. Interestingly, Bernthal (1939) observed significant
ventilatory increases when they perfused isolated canine carotid bodies with 45°C blood.
In humans, greater ventilation occurs in hyperthermic compared to normothermic lowintensity euoxic exercise (i.e. exercise in normal oxygen conditions) (Chu, Jay, & White,
2007). An important note about the central control regulation of body temperature is that
it is predominantly the blood temperature entering the brain (carotids) or surrounding the
hypothalamus that signal body temperature. For this reason, measuring temperature of
the blood passing by the hypothalamus (e.g. using a tympanic thermometer) has been
suggested to be optimal when studying the impacts of heat exposure (Lee et al., 2011).
Overall, in response to heat, there is an increase in blood flow to the skin, resulting in
more work for the cardiovascular system to meet the blood flow (and oxygen) demands
of vital organs such as the brain. It is likely that many of the health challenges, but also
chronic benefits associated with passive heating are a result of this increased demand on
the cardiovascular system.
1.4 Mechanisms of heart rate variability (HRV) improvement
To ensure survival, an organism must be able to respond to its environment. The
ability to outrun a predator, for example, relies on the “fight-or-flight” response
characterized by changes in heart rate, blood flow to working muscle, pupil dilation and
fuel mobilization. While we are usually no longer faced with these types of threats to
survival, a healthy human heart must be able to respond to environmental changes, both
9

psychological (e.g. interpersonal and work stressors) and physiological (e.g. heat, illness
and exercise).
The sinoatrial (SA) node is considered the heart’s pacemaker, given its ability to
spontaneously contract without nervous input approximately 100 times per minute. The
autonomic (involuntary) nervous system influences heart rate via sympathetic (SNS) and
parasympathetic (PNS) activity. The SNS, associated with fight or flight, is normally
considered the accelerator, while the PNS, associated with rest and digest, is normally
considered the brakes of the system. Through predominantly PNS activity acting through
the vagus nerve innervating the SA node, resting heart rate is maintained between 60 and
70 beats per minute on average. Parasympathetic terminals in the SA node slow
depolarization through the release of acetylcholine. Acetylcholine is a small
neurotransmitter (chemical messenger) that binds to and activates membrane potassium
(K+) channels, thereby increasing K+ permeability. This results in cardiomyocyte
hyperpolarization (i.e. further away from the threshold necessary for depolarization and
the stimulus for myocardial contraction) and a decreased rate of SA node firing (Berntson
et al., 1997). The SNS also acts through the vagus nerve to modulate heart rate.
Sympathetic terminals speed SA node rhythm by releasing Norepinephrine (a
neurotransmitter), which acts on β1 receptors to stimulate a signal cascade within the cell
(Berntson et al., 1997). Further SNS regulation occurs with the release of
adrenomedullary catecholamines (hormones involved in the stress response) (Berntson et
al., 1997).
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Heart rate variability (HRV) is a measure of SNS and PNS regulation of heart
rate, where greater variability is indicative of a greater capacity to respond to a changing
environment. Lower variability due to reduced PNS control is a predictor of
cardiovascular morbidity and mortality (Routledge, Campbell, McFetridge-Durdle, & Bacon,
2010). Short-term recordings of HRV ranging from 2-5 minutes are used to produce three

spectral components: very low frequency (VLF), low frequency (LF) and high frequency
(HF) (Camm et al., 1996). The HF component consists of vagal activity, while the LF
component is a combination of SNS and PNS activity. The LF/HF ratio represents
sympatho/vagal balance, and therefore a lower ratio is indicative of greater vagal activity
To measure HRV, the N-N (normal-to-normal) intervals are calculated from
electrocardiogram (ECG) recordings of the heart’s electrical activity. N-N intervals are
the period between adjacent QRS complexes resulting from sinus node depolarization
(Reed, Robertson, & Addison, 2005) (see Figure 1). It should be noted that N-N interval
refers to R-R

11

Figure 1.

Figure 1. A normal, one-cycle ECG signal measured in the standard lead V6.
The RR interval is the time between two successive R waves. P represents atrial
depolarization followed by a delay as the electrical activity passes through the AV
node. The QRS complex represents ventricular depolarization, and the T wave
represents ventricular repolarization.

12

intervals that have been processed as “normal”. Greater standard deviation of N-N
intervals (SDNN) is associated with better autonomic regulation, whereas reduced SDNN
has implications in chronic heart failure (Hooper, 1999), and may couple with the
inflammatory process to be a cause of the formation of atherosclerotic plaques (Sajadieh
et al., 2004). Moreover, HRV is altered in many disease states. For instance, postmyocardial infarction measures of vagal activity and overall HRV are lower (Cerati &
Schwartz, 1991). Loss of vagus activation during sleep has also been reported, and may

provide insight into the occurrence of nocturnal sudden death (Vanoli et al., 1995; Curtis
et al., 2007; Fan et al., 2008). Furthermore, decreased HRV index in post-MI patients
prior to discharge was found to be an independent risk factor for left ventricle dilation at
follow-up (Dambrink et al., 1994).
In chronic heart failure (CHF) patients, reduced HRV is indicative of reduced
PNS activity and may have prognostic value for the increased risk of sudden death
(Galinier et al., 2000; Nolan et al., 1992). In a 2000 study, Galinier et al. reported an
absent LF component in patients with severe CHF. Given that the LF component is
considered sympathetic control, it seems counterintuitive that it is missing, as increased
sympathetic drive correlates with the increased heart rate associated with heart failure. A
possible explanation is that in severe CHF all mechanisms are active in order to
compensate for the pathophysiology, and as a result there is no reserve to maintain
variability (Galinier et al., 2000). Nonetheless, time and frequency domain analysis of
HRV has been shown to provide insight into autonomic cardiovascular modulation
among hypertensives (Parati, Saul, Di Rienzo, & Mancia, 1995). Both males and females
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with systemic hypertension have reduced HRV, and lower HRV among normotensive
males is associated with a greater risk of developing hypertension (Singh et al., 1998).
In addition to CVD, HRV declines with aging. VLF, LF, and HF powers as well
as fractal dimensions have been shown to decline with age during both awake and
sleeping measures (Yeragani, Sobolewski, Kay, Jampala, & Igel, 1997). Furthermore,
Choi et al (2006) report an overall sympathetic activity increase and a concomitant
parasympathetic decline with aging that may account for the increased rate of CVD at
this time.
Various studies demonstrate HRV improvements with exercise. Cardiac
rehabilitation exercise interventions improve HRV measures post-myocardial infarction.
Leitch et al. (1997) reported improvements in SDNN, Total Power, HF power and LF
power following exercise training, and Oya et al. (1999) observed improved HF power
following aerobic training. Exercise is also associated with HRV improvements among
chronic heart failure (CHF) patients (Pietilä et al., 2002). Following six months of
exercise training, greater HF power and total R-R variability have been reported (Pietilä
et al., 2002). Furthermore, individuals with coronary artery disease (CAD) showed
improved R-R variability following two weeks of training (Iellamo, Legramante,
Massaro, Raimondi, & Galante, 2000).
Physical activity also improves HRV in non-clinical populations. In canine
models, aerobic exercise may reverse autonomic neural remodeling due to myocardial
infarction (Billman, 2009). In humans, SDNN (ms) (the Standard Deviation of all normal
R-R intervals) is significantly linked to VO2max, suggesting greater aerobic fitness is
14

associated with greater HRV (Aslani, Aslani, Kheirkhah, & Sobhani, 2011). Fitter
individuals also demonstrate less pronounced reductions in HRV during mental stress
(Hamer & Steptoe, 2007). These studies would indicate a beneficial effect of exercise on
autonomic control.
The response to thermal stress, very similar to the physiological response to
exercise stress, also influences HRV. Acutely, even mild heat stress (35°C for 30
minutes) is sufficient to influence components of HRV, and corresponds to a reduced HF
component and increased LF/HF ratio within minutes of heat exposure (Yamamoto,
Iwamoto, Inoue, & Harada, 2007). Lowered HF components, and elevated LF/HF ratios
indicate a reduction in vagal activity and an increase in sympathetic drive (Crandall,
Zhang, & Levine, 2000; Kinugasa & Hirayanagi, 1999). These changes suggest a
reduction in vagal tone (PNS withdrawal). Nagasawa et al. (2001) examined the effects
of a 40°C hot water bath on HRV in young (27.4 ± 9.6 years) and older (74.6 ± 10.7
years) participants. The results provide insight into the potential dangers of whole body
heating within an older population, as the HF component was significantly suppressed
within this group, but unaffected in the younger group. Thus hypotensive syncope (loss
of consciousness due to low blood pressure) may result from the reduction in sympathetic
tone detected during immersion (Nagasawa et al., 2001). Increased sympathetic activity
during passive heating (Crandall et al., 2000; Kinugasa & Hirayanagi, 1999; Nagasawa et
al., 2001; Yamamoto et al., 2007) counters the stress of rising core temperature. The
sympathetic response includes accelerated heart rate, increased sweating and ventilation.
It is possible that these acute sympathetic increases during heat stress improve HRV,
leading to enhanced PNS activity when the stressor is removed. For example, Kihara et
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al. (2004) examined the effects of sauna bathing on chronic heart failure patients.
Following two weeks of daily 15 minute far infrared-ray sauna exposure, patients showed
improvements in SDNN (ms) (an indication of improved HRV).
The mechanisms underlying these improvements are not fully understood,
however, Angiotensin II is thought to contribute (Buch, Coote, & Townend, 2002;
Townend, al-Ani, West, Littler, & Coote, 1995). Support for this theory includes the
lowered plasma renin levels in athletes compared to sedentary populations (Fagard et al.,
1985). Renin converts Angiotensinogen to Angiotensin I, which is subsequently
converted to Angiotensin II by Angiotensin Converting Enzyme (ACE) in the lungs.
Angiotensin II inhibits cardiac vagal activity (Townend et al., 1995). In an endurance
trained individual, lower plasma renin may contribute to less Angiotensin II and
therefore, less inhibition of vagal activity.
It is also suggested that nitric oxide is involved in exercise-induced improvements
in HRV. With respect to central modulation of vagal activity, NO has been shown to
increase the activity of central vagal motoneurons (Chowdhary & Townend, 1999). It
also modulates an indirect vagal inhibition of sympathetic cardiac responses (Chowdhary
& Townend, 1999). Research on these effects is limited, and further studies on passive
heating are required to determine how temperature influences autonomic regulation.
1.5 Heat therapy and vascular changes
Studies examining the effects of extreme temperatures (Hall, Buettner, Matthes, &
Gisolfi, 1994; Harris, Blackstone, Ju, Venema, & Venema, 2003) as well as more

conservative sauna therapies (Ikeda et al., 2001; Ikeda et al., 2005; Miyata & Tei, 2010)
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show that heat therapy provides many of the beneficial vascular changes associated with
traditional exercise.
Endothelial nitric oxide synthase (eNOS) generates nitric oxide (NO) in response
to various stimuli (Fleming & Busse, 2003), including oxidative stress and more
importantly, shear stress (Kojda & Hambrecht, 2005). These stressors stimulate eNOS to
synthesize NO from L-arginine (Ayajiki, Kindermann, Hecker, Fleming, & Busse, 1996;
Corson et al., 1996; Palmer, Rees, Ashton, & Moncada, 1988) to relax vascular smooth

muscle. Nitric oxide is anti-atherogenic through vasodilation, the inhibition of platelet
aggregation, smooth muscle cell proliferation and leukocyte adhesion to endothelial cells
(Knowles & Moncada, 1994). Similar to exercise, passive heating increases heart rate
and blood flow, ultimately exerting greater shearing force on the vasculature
(Tschakovsky, 2010). In support of this, 24 hours after bovine endothelial cells are
exposed to 42°C heat shock, eNOS is significantly increased (Harris et al., 2003).
Furthermore, maximal bradykinin-stimulated NO release is improved and the increased
rate of conversion from L-[14C] arginine to L-[14C] citrulline indicates enhanced eNOS
activity (Harris et al., 2003). Interestingly, more severe heat shock (45°C) is not
associated with increased eNOS expression or NO release (Harris et al., 2003). Another
animal study examining the effects of hyperthermia (>39°C elevation of rectal
temperature) on splanchnic circulation in a rat model shows a peak in local NO 1 hour
after heat exposure (Hall et al., 1994).
The role of sauna therapy in vascular remodeling has also been examined
(Sobajima et al., 2011). After myocardial infarction (MI) was induced in rats, they were
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placed in a dry sauna at 41°C for 15 minutes then 34°C for 20 minutes daily for 4 weeks.
Rats in the sauna group showed reduced left ventricular end-diastolic and end-systolic
dimensions as well as reduced MI-induced increases in left ventricle end-diastolic
pressure (Sobajima et al., 2011). Furthermore, decreases in vascular density in the noninfarcted myocardium were attenuated in the treatment group. Results indicate sauna
therapy reduced cardiac remodeling after MI in rats (Sobajima et al., 2011).
Although heat shock may ultimately improve eNOS and NO activities, exposure
to extreme temperatures is dangerous to human health. Nonetheless, animal studies
conducted using exposure to lower temperatures also yield promising results (Ikeda et al.,
2001; Ikeda et al., 2005). When Syrian golden hamsters are exposed to daily heating

(39°C for 15 min followed by 30°C for 20 min) over 4 weeks, aortic eNOS is
significantly increased (Ikeda et al., 2001). Furthermore, when the same treatment is
applied to cardiomyopathic hamsters, a significant increase in aortic eNOS mRNA is
reported (Ikeda et al., 2005).
1.6 The effects of estrogen on HRV
The steroid hormone estrogen has many cardioprotective effects. It is involved in
vascular smooth muscle contractility, proliferation, matrix formation and composition
(Farhat, Lavigne, & Ramwell, 1996), and potentiates NO activity on vascular smooth
muscle (Gilligan, Badar, Panza, Quyyumi, & Cannon, 1994). It is important to note that
these effects may be age-dependent, with benefits decreasing as time post-menopause
increases (Sherwood et al., 2007).
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Estrogen levels vary throughout the course of the menstrual cycle, with an
estrogen spike in the late follicular phase prior to ovulation and a decline in the luteal
phase. Estrogen mediates certain neuronal activity, including that which influences heart
rate, blood pressure and sleep (Miller & Duckles, 2008). As such, it is important to
consider menstrual cycle phase in the measurement of HRV. HF power generally
decreases in the luteal phase, while LF power and the LF:HF ratio tend to increase at this
time (Bai, Li, Zhou, & Li, 2009; Baker, Colrain, & Trinder, 2008; Leitch et al., 1997; Sato,
Miyake, Akatsu, & Kumashiro, 1995)

1.7 Hypertension and sauna therapy
Hypertension, defined as systolic blood pressure consistently over 140 mmHg and
diastolic blood pressure consistently over 90 mmHg (Hypertension Canada 2011,
www.hypertension.ca), is associated with increased risk of stroke and myocardial
infarction (Heart and Stroke Foundation), aneurysm, atherosclerosis, and heart failure
(Hypertension Canada 2011, www.hypertension.ca). It arises from defects in
endothelium-mediated vascular relaxation (Panza, 1997). Close to 19% of Canadian
adults have elevated blood pressure (Wilkins et al., 2010), placing them at greater risk of
these complications. This condition is particularly dangerous for females, as those with
high blood pressure are 3.5 times more likely to develop heart disease than those with
normal blood pressure (Corrao, Becker, Ockene, & Hamilton, 1990). An additional 20%
of the Canadian population is considered pre-hypertensive (Wilkins et al., 2010), with
elevated systolic blood pressure between 120-139 mmHg or diastolic blood pressure
between 80-90 mmHg. Pre-hypertensives are at greater risk of developing hypertension
(Chobanian et al., 2003), however, health-promoting lifestyle modifications such as diet
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and exercise are effective in reducing the risk of developing cardiovascular disease
(Chobanian et al., 2003). In fact, the ACSM recommends 30-60 minutes of continuous or
intermittent moderate-intensity aerobic exercise on most (or all) days of the week, and
resistance exercise 2 to 3 times per week (ACSM’s Guidelines for Exercise Testing and
Prescription, 8th Ed.). An acute bout of aerobic exercise is associated with a 5-7 mmHg
decline in blood pressure, with effects lasting up to 22 hours after an endurance session
(Pescatello et al., 2004). Furthermore, the greatest blood pressure declines are seen in
those with the highest resting values (Pescatello et al., 2004). However, despite the
effectiveness of exercise in the prevention and management of hypertension, adherence is
problematic. Uzun et al., (2009) followed a group of 150 hypertension patients for 1 year,
and found a mere 31% adherence to the recommended exercise program. Therefore,
other prevention strategies and therapeutic interventions should be evaluated for efficacy
and adherence. In particular, recent research also suggests sauna therapy as an effective
approach to improving blood pressure and reducing the risk of hypertension (Giannetti et
al., 1999; Imamura et al., 2001; Kihara et al., 2002; Yamaoka et al., 2004). Thus, heat

therapy may be a less time consuming and less strenuous intervention or adjunct therapy
to traditional methods.

1.8 Heat therapy and heart failure
In addition to animal studies, more recent research has examined the effects of
heat therapy for patients with chronic heart failure (CHF) and coronary risk factors
(Basford et al., 2009; Imamura et al., 2001; Kihara et al., 2002). Factors such as smoking,
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diabetes mellitus, hypercholesterolemia and hypertension are coronary risk factors as they
are associated with vascular damage and plaque formation. Repeated thermal therapy has
been shown to improve endothelial function in patients with one or more of these risk
factors (Imamura et al., 2001). 2 weeks of daily sauna exposure (15 minutes at 60°C
followed by 30 minutes of rest with blankets) significantly increased percent flowmediated dilation in this group (Imamura et al., 2001). These benefits extend to the CHF
population as well. A 2004 study explored the effects of sauna treatment on patients with
New York Heart Association functional class II or III CHF and at least 200 premature
ventricular contractions every 24 hours. Participants underwent sauna therapy (15
minutes at 60°C followed by 30 minutes of rest with blankets) 5 times per week over 2
weeks. Results indicate increased heart rate variability, and a reduction in concentration
of plasma brain natriuretic peptide (a substance secreted due to excessive cardiomyocyte
stretching concomitant with heart failure) (Kihara et al., 2004).
Additional research on the long-term effects of sauna therapy for patients with
CHF also shows positive outcomes (Kihara et al., 2009). 64 patients with New York
Heart Association class III and IV heart failure were treated 5 times per week during
admission and twice weekly after discharge with the same protocol (15 minutes at 60°C
followed by 30 minutes of rest with blankets). Control patients were provided with
traditional therapy. At 60 months follow-up, 68.7% of the control group had suffered
cardiac events due to heart failure or cardiac death, while significantly fewer (31.3%)
sauna patients experienced an event (Kihara et al., 2009).
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1.9 Heat shock proteins
Interestingly, heat shock proteins (HSPs) are biological molecules associated with
cellular stress, and are in fact, preferentially increased after organisms are exposed to
several stressors (Morimoto, 1998). More specifically, as their name implies, a primary
stimulus for an increase in HSPs is elevated temperature or heat (Bathaie, Jafarnejad,
Hosseinkhani, & Nakhjavani, 2010; Fujita et al., 2011). In fact, the preferential transcription

of HSP genes was first discovered when Drosophila were exposed to high temperatures
(Ritossa, 1962). An important characteristic of HSPs, the 70 kilodalton HSPs in
particular, is that given their functions as molecular chaperones, assisting in protein
folding, protein degradation and protein translocation (Beckmann, Mizzen, & Welch,
1990), cells and organs with elevated HSPs are better protected against future stresses.
This is what is known as heat preconditioning, but could be used to describe any stress
that fortifies an organism (e.g. exercise preconditioning).
While research has shown increases in Hsp70 to be beneficial, other studies
suggest HSPs may be indicative of a diseased state, or even contribute to autoimmune
disease (Alam et al., 2009; Nakhjavani et al., 2010). The examination of Hsc70 (the
constitutive member of the HSP70 family) transgenic mice revealed that damage to
pancreatic β-cells resulted in an increased incidence of Diabetes and a greater recruitment
of serum cytokines and lymphocytes in Hsc70 transgenic mice (Alam et al., 2009).
Examination of Hsp70 in diabetic humans shows significantly greater concentrations of
serum Hsp70 in diabetics compared to non-diabetics (Nakhjavani et al., 2010), as well as
higher levels of Hsp70 in patients who were diabetic for 5 years or longer (Nakhjavani et
al., 2010). However, Gruden et al. (2009) and Milne and colleagues (unpublished
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observations) have observed that very few individuals (<5%) express Hsp70 in the
circulation, whereas the expression of antibodies against HSPs are in much greater
concentration. Also, higher levels of anti-Hsp70 antibodies are correlated with improved
odds ratios in Type 1 diabetics (Gruden et al., 2009). These mixed results regarding the
potential benefits or detriments of increased Hsp70 reveal the need for further studies to
determine the effects of these proteins.
There is also evidence to suggest that the induction of Hsp70 is sex-specific.
After treadmill running, male rats have a twofold increase in cardiac Hsp70 compared to
females (Paroo, Dipchand, & Noble, 2002). When this exercise was performed by
ovariectomized females, increases in cardiac Hsp70 were similar to those in male rodents
(Paroo, Haist, Karmazyn, & Noble, 2002). These differences extend to skeletal muscle as
well. Post-exercise induction of Hsp70 at the protein and mRNA levels is significantly
greater in male rats compared to females (Paroo, Dipchand, & Noble, 2002). Further,
Shinohara et al. (2004) have observed that exogenous estrogen inhibits the heat induced
accumulation of Hsp70 in rats. Since exercise may produce sex-specific increases in
Hsp70 and post-ischemic cardiac function, it is of interest to determine whether heat
stress is also associated with differences in Hsp70 induction between male and female
humans.
Interestingly, the heat inducible 90 kilodalton HSP, Hsp90, has a role in
endothelial nitric oxide synthase (eNOS) modulation (eNOS is an enzyme primarily
responsible for the generation of NO in the endothelium) (García-Cardeña et al., 1998;
Gratton et al., 2000; Takahashi & Mendelsohn, 2003). This eNOS is maintained in an
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inactive state by interaction with caveolin-1 protein (Navarro, Anand-Apte, & Parat,
2004) that upon stimulation is reduced, thereby freeing eNOS to bind to calmodulin
(CaM) (Navarro et al., 2004). Takahashi & Mendelsohn (2003) suggest Hsp90 is
involved in NO synthesis by interaction with Ca2+/CaM. When eNOS is not saturated
with CaM, Hsp90 decreases the EC50 (50% effective dose) for Ca2+ and CaM as well as
dose dependently increasing the amount of CaM bound to eNOS (Takahashi &
Mendelsohn 2003). Therefore, since eNOS is a CaM-dependent enzyme, Hsp90
increases NO synthesis and vasodilation. Also, it is possible that passive heating may
improve vasodilation through a more direct Hsp90/eNOS mechanism since eNOS exists
in a complex with Hsp90 in endothelial cells and the endothelial lining of intact blood
vessels (Garcia-Cardena et al., 1998). It is suggested that shear stress acts as a stimulus
to increase the molecular attraction of eNOS and/or Hsp90 for each other, increasing the
association of proteins and the activation of eNOS (Garcia-Cardena et al., 1998). This
activation may occur through the allosteric modulation of eNOS by Hsp90 via
conformational change or stabilization of the eNOS dimer (Garcia-Cardena et al., 1998).
Therefore, heat exposure may stimulate the Hsp90 activation of eNOS and improve
vasodilation.
Further, HSPs play a role in exercise or heat preconditioning in mammals and it is
thought that during exercise or heat stress, the accumulation of denatured proteins due to
inherent cellular stress (e.g. increased temperature, reactive oxygen species, calcium
transients, adrenergic signaling, etc.) increases the demand for chaperones (HSPs) and
that an accumulation of HSPs in this regard produces cardioprotective effects (Noble,
Milne, & Melling, 2008). For example, rats exposed to exercise training for as little as a
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single 60 min bout that is concomitant with an increase in cardiac Hsp70 demonstrate
improved post-ischemic cardiac function (Locke, Tanguay, Klabunde, & Ianuzzo, 1995).
Paroo, Haist, Karmazyn & Noble (2002) also observed improved post-ischemic left
ventricular developed pressure, maximal rate of contraction and relaxation, and a
decrease in left ventricle end-diastolic pressure after treadmill running in rats. Similarly,
rats exposed to longer training periods (e.g. daily running bouts over days to weeks) have
improved post-ischemic recovery associated with increased myocardial Hsp70 (Locke et
al., 1995; Le Page et al., 2009). However, the role of HSPs in physiological protection
does not stop at the heart. In a study of streptozotocin-induced diabetic rats, hot tub
therapy was associated with a significant increase in Hsp70 and decrease in advanced
glycation end products (AGEs, which are markers of chronically elevated blood glucose,
a negative consequence of diabetes), potentially due to Hsp70 reducing glycation
(Bathaie, Jafarnejad, Hosseinkhani & Nakhjavani, 2010).
Since both exercise (see above) and heat stress (Bathaie et al., 2010; Fujita et al.,
2011) stimulate the HSP response, either of these interventions may benefit the human

population.
1.10 HSPs and diabetes
Diabetes is characterized by elevated blood glucose (hyperglycemia). Type I
Diabetes (TID) is an autoimmune condition, where the pancreas is not capable of
producing the hormone insulin, which is responsible for glucose uptake in tissues. As a
result, glucose accumulates in the blood, creating a hyperglycemic state. Type II
Diabetes (TIID) occurs when the pancreas is incapable of producing sufficient amounts
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of insulin, or various tissues are insensitive to insulin. Just as in TID, glucose is unable to
enter the cell and remains in the blood (Canadian Diabetes Association,
www.diabetes.ca). In Windsor-Essex County, 7.2% of residents have been diagnosed
with diabetes.
Interestingly, poorly managed diabetes increases an individual’s risk of
cardiovascular disease and approximately 80% of diabetics suffer a heart attack or stroke
(Canadian Diabetes Association, 2011). The diabetic state is characterized by elevated
triglycerides and decreased high density lipoproteins (HDL) (Dokken, 2008). Low
density lipoproteins (LDL) are often smaller and more dense in diabetics, leading to a
greater ability to infiltrate the arterial wall and become oxidized (Dokken, 2008). The
oxidized particles attract immune cells, leukocytes, leading to atherosclerotic plaque
formation (Chan, 1998). Furthermore, methylglyoxal (MG) is a glycating agent often
present in greater quantities in diabetics (Rabbani et al., 2011). In vitro studies of
MG(min)-LDL (the equivalent that occurs in vivo) show decreased LDL particle size,
increased proteoglycan binding and aggregation, indicating MG modification produces
small, dense and more atherogenic LDLs (Rabbani et al., 2011).
Insulin is necessary for glucose uptake, and is important in regulating triglyceride
(TRG) levels in the blood (Shen, 2007; Dokken, 2008). Insulin enhances the enzyme
lipoprotein lipase, which cleaves triglycerides into free fatty acids (FFAs) for uptake into
tissues (Shen, 2007). It also reduces hormone sensitive lipase, an enzyme that releases
FFAs into circulation (Shen, 2007). With insufficient insulin production, as seen in
diabetes, FFAs uptake is reduced and release into circulation is increased, resulting in
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hypertriglyceridemia (Shen, 2007). This activity contributes to endothelial dysfunction,
atherosclerosis and macrovascular disease.
Exercise and heat are both physiological stresses that enhance HSP production
(Bathaie et al., 2010; Fujita et al., 2011; Lancaster & Febbraio, 2005; Ogawa et al., 2011;
Walsh et al., 2003). Studies of diabetic animals show that Hsp70 is significantly lower in

these groups when compared to healthy controls (Atalay et al., 2004; Yamagishi,
Nakayama, Wakatsuki, & Hatayama, 2001). Furthermore, although exercise training

increases Hsp70, diabetic animals show an attenuated response (Atalay et al., 2004). The
same is true when Hsp70 is induced through hyperthermia as diabetic animals show
impaired cytoprotective abilities (Yamagishi et al., 2001). However, an importance of
timing of induction is indicated by the observation that Hsp70 protects against obesityinduced insulin resistance, such that mice exposed to heat therapy once per week over 16
weeks were protected against high fat diet induced hyperglycemia, hyperinsulinemia and
elevated HOMA-IR (Chung et al., 2008). Diabetic humans also have altered HSP
expression. At baseline, Kurucz et al. (2002) found a significant difference in Hsp-72
(Hsp70) mRNA concentration in muscle between diabetics and healthy controls, and a
positive correlation between Hsp-72 mRNA and the rate of insulin stimulated glucose
oxidation (Kurucz et al., 2002). Therefore, these results indicate that increasing Hsp70
may not only prevent the negatives of improper diet but also improve glucose handling.
Therefore, the benefits and potential use of circulating HSPs are not completely
understood. While preliminary observations have been made on circulating Hsp70 (see
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above), very little is known about Hsp90, even though it has an intimate relationship with
the endothelium.
1.11 Sauna therapy and psychological well-being
Depressive and anxiety disorders are often treated with pharmacotherapy,
however, exercise has been shown to be effective in the management of these disorders
(Nahas & Sheikh, 2011; Helmich et al, 2010; Babyak et al., 2000; Broman-Fulks et al.,
2004; and Broocks et al., 1998). For example, a significant reduction in Hamilton Rating
Scale for Depression scores suggests the role of exercise as a monotherapy or adjunct to
traditional treatments for depression (Nahas & Sheikh, 2011). Furthermore, moderate
intensity exercise 3 times per week is effective in the treatment of patients with major
depression (Babyak et al., 2000). These benefits extend to anxiety disorders as well, as
Broman-Fulks et al. (2004) show that high and low intensity exercise significantly
reduced anxiety sensitivity. In addition, regular aerobic exercise is associated with
significant clinical improvements in patients with panic disorder when compared to
placebo (Broocks et al., 1998). The proposed mechanisms underlying these
improvements include increasing serotonin and central norepinephrine neurotransmission
as well as raising the concentration of endorphins (Helmich et al., 2010). Interestingly,
endorphins are involved in heat adaptation in the central nervous system (Vescovi &
Coiro, 1993) and have been shown to attenuate the physiological response to thermal
stimuli (Holaday, Wei, Loh & Li, 1978). Based on the role of endorphins in both
exercise and heat stress, it is possible that thermal therapy may produce some of the
similar psychological benefits as exercise. TRPv3 thermosensitive receptors, when
selectively activated have anxiolytic and antidepressant effects in mice (Moussaieff et al.,
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2008). Whether passive heating has the same effect is unknown, however an
uncontrolled study of bamboo charcoal kin use in Japan revealed lower anxiety levels
among participants following heat exposure (Hayasaka et al., 2008). Others have
measured salivary cortisol, a hormone elevated during physical and emotional stress,
before and after spa bathing with 42°C water (Toda, Morimoto, Nagasawa, & Kitamura,
2006). Cortisol was lower following bathing, with a more pronounced effect in those
with higher levels prior to bathing (Toda et al., 2006).
Masuda et al (2005) examined the effects of daily infrared sauna treatment in
depressed inpatients. Results showed a reduction in somatic complaints, and
improvements in hunger and relaxation scores (Masuda et al., 2005). In addition,
significant increases in plasma ghrelin (a hunger hormone) concentration and daily
caloric intake were observed (Masuda et al., 2005). Research on the effects of passive
heating in depressive and anxiety disorders is limited, and further studies are required to
better understand these effects.
1.12 Risks of heat therapy
While outcomes show the potential benefits of sauna therapy, risks are often cited
(Kukkonen-Harjula & Kauppinen, 2006; Press, 1991). Consequently, it is essential to
ensure this treatment is safe. Basford et al. (2009) examined the effects of sauna bathing
in New York Heart Association class III and IV CHF patients. Participants underwent
sauna bathing three times a week over four weeks in a 60°C sauna for 15 minutes each
day. The intervention was found to be safe and well-tolerated in this group (Basford et
al., 2009). Furthermore, sudden deaths resulting from sauna baths are infrequent,
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especially in younger populations. Among men 60 years and older, sauna related deaths
occurred at a rate of 1 in 0.4 million baths (Kukkonen-Harjula & Kauppinen, 2006).
These incidents are less frequent in the 50-59 year group (1 in 2.3 million baths), and are
least likely to occur among 40-49 year olds (1 in 9 million baths) (Kukkonen-Harjula &
Kauppinen, 2006).
1.13 Summary
In conclusion, the effects of exercise on markers of health and disease prevention
are well known. However, only half of Windsor-Essex county residents meet the
recommended daily physical activity guidelines. Sauna therapy may be an effective
method for reducing the negative health outcomes associated with physical inactivity, for
the reasons described above but also because improvements in vascular function have
been observed after only 75 minutes of sauna exposure per week (Kihara et al., 2002,
2009; Miyata & Tei, 2010). This is half of that recommended if using exercise (~150

minutes). Further, cardiovascular improvements such as flow-mediated dilation (FMD)
(Kihara et al., 2002; Nguyen, Naseer, & Frishman, 2004), and improved endothelial nitric

oxide synthase (eNOS) production (Ikeda et al., 2001; Ikeda et al., 2005) have been
reported after as little as only 2 weeks of thermal therapy, and heat therapy may even be
beneficial for individuals with metabolic diseases such as Diabetes. Improvements in
glycemic control such as enhanced insulin sensitivity and improved fasting plasma
glucose have been observed after a similarly short duration of hot tub therapy (Hooper,
1999). As such, it is essential to investigate alternative approaches to exercise and
pharmacotherapy in an attempt to reduce the risk of cardiovascular and metabolic disease
among adults, especially those more at risk for developing chronic diseases but before the
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spikes in chronic disease have occurred (i.e. middle-aged). Thermal therapy in the form
of daily sauna bathing may provide an alternate or adjunct prevention strategy against
these risk factors.
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Chapter 2
2.1 Introduction
Cardiovascular disease (CVD) is the second leading cause of death among
Canadians (Statistics Canada, 2011), with heart disease and stroke accounting for 21.3%
and 5.8%, respectively, of all deaths in 2008 (Statistics Canada, 2011). These adverse
cardiovascular events cost the Canadian economy an estimated 20.9 billion dollars in
2008 (Heart and Stroke Foundation, 2011), placing an enormous burden on health care
systems. Fortunately, CVD has a number of modifiable risk factors including
hypertension, blood cholesterol, diabetes, obesity, physical inactivity, smoking and stress
(Heart and Stroke Foundation, 2011). Lifestyle modifications such as diet and exercise
effectively reduce the risk of developing CVD (Chobanian et al., 2003). Despite these
benefits, many Canadians fail to meet the recommended 150 minutes of moderate to
vigorous exercise each week (Canadian Society for Exercise Physiology, 2012; Statistics
Canada, 2011), and many of those already diagnosed with risk factors such as
hypertension fail to exercise regularly (Uzun et al., 2009). Furthermore, musculoskeletal
injuries and fear of becoming injured also limit exercise participation (Perri et al, 2002).
Interestingly, when lifestyle modifications are not sufficient to reduce blood pressure,
cholesterol or blood glucose, pharmacotherapy may be introduced, but still, adherence
remains problematic. For example, antihypertensive drug use adherence is influenced by
age, gender and cost among other factors (Munger et al., 2007).
Therefore, sauna bathing may be a suitable alternative for individuals who are
unable to participate in regular physical activity. Sauna treatment in clinical populations
and individuals with coronary risk factors has been associated with symptom
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improvement and reduced risk of cardiovascular disease (Kihara, 2004; Kihara, 2009;
Imamura, 2001). Chronic heart failure (CHF) patients who underwent 2 weeks of daily
15 minute sauna treatment showed improved HRV (increased SDNN), and fewer
premature ventricular contractions (Kihara, 2004). In an investigation of the long-term
effects of sauna bathing among CHF patients, Kihara et al. (2009) reported fewer cardiac
events after 60 months. Vascular endothelial function has also been shown to improve
following sauna treatment, as percent flow mediated dilation (%FMD) among individuals
with 1 or more coronary risk factor significantly improved (Imamura et al., 2001).
Furthermore, improvements in glycemic control such as enhanced insulin sensitivity and
improved fasting plasma glucose have been observed after short duration of hot tub
therapy (Hooper, 1999), and sauna bathing may improve measures of psychological
health. For example, spa bathing with 42°C water has been associated with lower cortisol
(a stress hormone) levels (Toda, Morimoto, Nagasawa, & Kitamura, 2006) and the effects
of thermal therapy on depressed patients are also promising since daily infrared sauna
treatment of depressed patients results in fewer somatic complaints, and improved hunger
and relaxation scores (Masuda et al., 2005).
The mechanisms underlying these improvements are still unconfirmed. Given the
physiological response to passive heating (i.e. elevated heart rate and cardiac output,
increased sweating and ventilation) it is possible that these improvements occur in the
same manner as with aerobic exercise. In addition, it is unknown whether the benefits of
sauna bathing extend to a generally healthy population, indicating a need for further
study. Should sauna exposure improve CVD risk factors, it may serve as an alternative or
adjunct to traditional lifestyle interventions aimed at reducing the onset of CVD.
58

Objectives
The primary objective of this experiment is to determine whether short-term sauna
treatment improves markers of cardiovascular, metabolic and psychological health in
sedentary middle-aged males and females.
2.2 Hypothesis
We hypothesize that passive heating will be associated with health improvements
as it is similar to exercise stress. Changes in blood flow, ventilation, and sweat
production occur during acute exercise as well as passive heating. As such, we predict
the following:
1) Two weeks of daily sauna treatment will improve markers of metabolic,
cardiovascular and psychological health.

2.3 Methods
Participants
To examine the physiological and psychological adaptations that occurred with 2
weeks of sauna use, middle-aged males (n=2) and females (n=3) were recruited from the
Windsor-Essex Region including the University of Windsor campus. Participant
characteristics are presented in Table 2.1.
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Table 2.1. Participant characteristics.

Measure

Mean

±

SD

Age (y)
Female (n)
Male (n)
Height (cm)
Weight (kg)
Body Mass Index (kg/m2)
Body Fat %
Fat Mass

46.4

9.07

169.2
73.84
25.66
28.56
25.93

±
3
2
±
±
±
±
±

VO2peak (ml/kg/min)

20.76

±

7.42

0.42
10.86
1.21
9.56
14.42
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Informed Consent and Initial Questionnaires
Prior to testing, all participants were seated with an informed consent document.
They were provided a verbal explanation of the purpose, risks, benefits, and protocol and
were asked to read the consent form prior to signing. Participants were also informed
that they were free to withdraw from the study at any point with no consequences.
Testing occurred in the Physical Activity and Cardiovascular Research (PACR)
laboratory at the University of Windsor. Upon entering the lab, participants were seated
and the experiment and risks were explained. Participants were then required to read and
sign informed consent, complete a Physical Activity Readiness Questionnaire (PAR-Q,
Appendix A), complete a Participant Information Sheet (Appendix B), and complete a
Risk Factor and Medication sheet (Appendix C) before participation in the study.
Participants were excluded if they met any of the criteria outlined by Nguyen et al., 2004
(Table 2.2), or if they had any limiting medical conditions or were taking medications
that may have caused negative effects during sauna bathing. All participants were asked
not to make any lifestyle changes (ie. diet, exercise) for the duration of the study and
follow-up period. This protocol was approved by the Research Ethics Board at the
University of Windsor.

61

Table 2.2. Exclusion criteria to sauna use.
Exclusion criteria
Limiting
physical
conditions

Rationale
•

Alcohol consumption

•

Increases the risk of
hypotension, fainting, and
arrhythmias (Roine et al,
1992).
Increase the risk of
hypotension, fainting, reinfarction, arrhythmias, and
sudden death (Keast et al,
1988; Eisalo et al, 1988;
Luurilia, 1992)
Iisalo et al, 1969; Luurila et al,
1989; Barkve et al, 1986

Severe aortic stenosis, unstable
angina pectoris, recent myocardial
•
infarction, decompensated heart
failure, and cardiac arrhythmias.
• Hypotension in patients on βblocker and short-acting
nitroglycerin
•
• Orthopedic conditions that prevent
the completion of a cycle ergometer
test.
• 2 or more cardiovascular disease
risk factors.
• Pregnancy.
Medications
• Diuretics
• All may impair heat loss and
increase the risk of heat related
• Anticholinergics
illness.
• Barbiturates
• Beta-blockers
• Antihistamines
Criteria were established from those outlined by Nguyen et al. 2004.
•
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Design
Following initial screening, participants underwent baseline blood pressure and
HRV measurements as part of the familiarization process. Participants were then asked
to return to the lab within 1 week for baseline physiological and psychological testing
(resting HR, BP, blood glucose, hematocrit, State Trait Anxiety Inventory (STAI) and
VO2). These physiological and psychological tests were completed on 3 separate
occasions: baseline, after 2 weeks of normal activity and immediately prior to sauna
therapy and 2-3 days after 2 weeks of sauna therapy. In this regard, participants acted as
their own controls for the initial 2 week baseline period. A flowchart of the study
timeline is diagrammed in Figure 2.1. On each testing day, participants were asked to
report to the PACR lab after an 8 hour fast. Once there, the following procedures were
completed in the order of their appearance.
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Figure 2.1
Recruitment

DAY 1

DAY 2

Informed
Consent/Familiarization

Initial Testing
(STAI, HR, BP, BF%, HRV,
MVO2, Hct, BG, HDL, LDL,
Chol)

2 weeks
normal activity

DAY 16

Pre-Sauna Therapy Testing
(STAI, HR, BP, BF%, HRV,
Hct, BG, HDL, LDL, Chol)

10 session of sauna
therapy over 2 weeks

DAY 32

Final Testing
(STAI, HR, BP, BF%, HRV,
Hct, BG, HDL, LDL, Chol)

Tympanic
Temp. and HR
during sauna

Analysis

Figure 2.1. Flow diagram of study procedures. Note that peak VO2 analysis was only performed on
the first testing session. STAI (State Trait Anxiety Inventory), HR (resting heart rate), BP (resting
blood pressure), BF% (percent body fat), HRV (heart rate variability), Hct (hematocrit), BG (blood
glucose), HDL (high density lipoprotein), LDL (low density lipoprotein), Chol (cholesterol).
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Testing Days
State Trait Anxiety Inventory (STAI)
After the initial meeting and subsequent to informed consent, Group II
participants were seated and required to complete the STAI (Appendix C). They were
instructed to follow the instructions on the form and the researcher calculated the scores
at a later time. The STAI is designed to measure temporary state anxiety and more
general and long-standing trait anxiety. The inventory consists of 2 sections, 20 questions
each using 4 point Likert items. The number on the Likert scale is positively correlated
with the anxiety related to the question. The STAI validity has been assessed, and is
correlated with the Anxiety Scale Questionnaire and Manifest Anxiety Scale with
correlation scores of .73 and .85, respectively (Spielberger, Reheiser, Ritterband, Sydema
& Unger, 1995). Furthermore, Rule and Traver (1983) determined the reliability of the
State Anxiety measure to be .40 and Trait Anxiety measure to be .86.
Heart Rate Variability (HRV)
Participants reported to the lab following an 8 hour fast as well as having
refrained from caffeine consumption for 8 hours. The investigator placed 3 electrodes on
the participant’s chest, one below each clavicle and one on the lower left side of the
abdomen. The participant lay supine on a bed for 20 minutes in a quiet temperature
controlled room with the lights dimmed. Following the rest period, 10 minutes of
electrocardiograph data was recorded for later analysis. R-R interval data was recorded at
a sampling frequency of 1000 Hz, and signals were converted to digital using a data
acquisition board (PowerLab 8/30, ADInstruments Inc., Colorado Springs, CO, USA).
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Recordings were edited using an ECG editor program to detect R-R intervals. R-R
interval data was then analyzed using an HRV analysis program.
Blood pressure, body composition
Resting arterial blood pressure (BP) and resting heart rate (HR) were assessed
after 10 minutes of seated rest using a non-invasive automatic device (DinamapProcare
200/Carescape 200, GE Healthcare Canada, ON, Canada). 4 measurements were
obtained, the first was discarded and the remaining 3 were averaged.
Body composition was measured using air-displacement plethysmography
(BodPod, Life Measurements Inc., Concord, CA, USA). Prior to entering the BodPod,
participant height was recorded. Participants were instructed on the breathing protocol,
asked to remove excess clothing and jewelry and wear the appropriate cap. Females wore
either a swimsuit or spandex shorts and bra and males wore athletic shorts. Once the
participants received instructions and weight was measured, they entered the BodPod and
followed on-screen breathing instructions.
Fasting plasma glucose (FPG), blood lipids
Blood glucose, total cholesterol, high density lipoproteins (HDL), triglycerides,
low density lipoproteins (LDL), non-HDL, and LDL/HDL were measured using a
Cholestech LDX system (Cholestech LDX®, Cholestech, USA) and fingerstick blood.
For each sample, the investigator wore latex gloves, inserted a new needle into the
lancing device (Accu-Check Softclix, Roche Diagnostics) and swabbed the participant’s
skin with an alcohol swab. The blood drop was collected in an anticoagulant coated
capillary tube (Cholestech) and a plunger was inserted to force the blood into the
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collection tray for analysis. This test is highly comparable to The Centers for Disease
Control and Prevention’s Cholesterol Reference Method and other laboratory tests.
Hematocrit

A second set of capillary tubes were used to collect fingerstick blood .
Hematocrit was measured using a microhematocrit centrifuge (Statspin CritSpin, Iris
Sample Procssing, USA) with manual card reader.
Maximal oxygen consumption (VO2peak)
Participants were fitted with a telemetric heart rate monitor (Polar, Canada).
Participants were asked to mount an Ergoline cycle ergometer and seat height and handle
bar distance were adjusted. A mouthpiece for gas analysis was fitted with a head strap.
The subject was asked to begin pedaling at 80 rpm and to maintain this pace for the entire
test. If the participant fell below 60 rpm, the test was terminated. Volume of oxygen
consumed (VO2), volume of carbon dioxide consumed (VCO2), respiratory exchange
ration (RER) and heart rate (HR) were recorded throughout the test using an online gas
analysis system (MediSoft, Ergocard). After 2 minutes of unloaded cycling, the
resistance was increased in an incremental fashion 25W/min until volitional exhaustion.
Throughout the test, verbal encouragement was given in an attempt to help the participant
achieve maximal effort. Maximal effort was determined if 2 of the following 4 criteria
were met: a heart rate within 10 beats of age predicted maximum; inability to maintain 60
rpm on the cycle ergometer; a plateau in VO2 even though resistance had been increased;
a respiratory exchange ratio greater than or equal to 1.1. Moreover, the test was stopped
if the participant exhibited any physical signs of distress (such as pale skin, confusion, a
reduction in heart rate with an increase in intensity, pains in the chest, etc.) that would
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have been indicative of an inability to meet the demands of exercise. After completion of
the test, the subject was required to remain on the cycle, with no resistance until heart rate
returned to within 10 beats of the initial stage. Subsequently, the mouthpiece was
removed and the subject was asked to dismount the cycle. The VO2peak test was
performed only on the first testing day. The remaining 3 testing days included all
physiological measures except VO2peak.
Sauna treatment
Female participants reported to the Windsor Squash and Fitness Club, and male
participants to the University of Windsor St. Denis Centre for 10 visits over 14
consecutive days, and were permitted to miss only one session if necessary. Prior to
entering the sauna, tympanic temperature and weight were measured. Participants wore
either a swimsuit, or spandex shorts and bra and were fitted with a telemetric heart rate
monitor and watch to record heart rate throughout the sauna bath (Polar, USA). The
sauna thermostat was set to approximately 80-90°C to account for other fitness center
members entering and leaving the sauna throughout the participant’s session. Actual
sauna temperature was recorded between 50-60°C during all sauna baths.
Participants were informed to remain seated comfortably in the sauna and
reminded that they were free to exit the sauna at any time should they experience any
discomfort (ie. dizziness), and bottled water was available throughout the testing session.
Tympanic temperature was recorded before, midway through, and upon completion of the
15 minute sauna bath (Braun ThermoScan 5 IRT4520). Upon exiting the sauna bath, the
participant was weighed to account for sweat loss. The participant was asked to lie on a
massage table while covered with a thermal blanket (SOL thermal bivvy) for 30 minutes.
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Tympanic temperature was recorded every 5 minutes during this period. Central
thermoreceptors located in the brain detect changes in blood temperature. Therefore
tympanic measurement was used as it provides an estimate of the temperature of blood
entering specific brain centres (Lee et al., 2011). Participants were permitted to leave
when heart rate was within 10 beats of the initial stage. Sauna treatment was repeated for
10 days over a 2 week period as has been previously outlined. Within 2-3 days of the
final sauna treatment, participants returned to the PACR lab for post-sauna testing which
included the same measures outlined above except for VO2 testing.
Statistics
Statistical analysis was performed using PASW version 18.0 (or latest version).
All data including descriptive statistics are presented as means ± standard deviations
(SD). A repeated measures ANOVA (RM ANOVA) was performed to compare baseline,
pre-treatment, and post-treatment measures. Upon finding significant main effects,
individual group means were compared using Least Significant Difference (LSD) post
hoc analysis. In a recent study, Kihara et al. (2002) examined the effects of sauna
treatment for men and women with CHF and did not note any sex differences in the
ability of the therapy to improve cardiovascular health. Initial fitness (as measured by
VO2peak) and body fat percentage were analyzed as covariates. Mean differences were
considered statistically significant where p<0.05.
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2.4 Results
Physiological Responses to Passive Heating
Tympanic temperature and heart rate were recorded for each sauna session.
Complete data was available for only 4 participants. Tympanic temperature increased
significantly among all participants (mean baseline temperature 36.0°C ± 0.8 vs mean
post-sauna temperature 37.9°C ± 0.6, p<0.001; Table 2.3). This change in tympanic
temperature occurred during the time in the sauna, but was maintained at approximately
1oC higher than pre-sauna values for the 30 minute period under the thermal blanket
(Table 2.3, Figure 2.2).
Heart rate was significantly increased by approximately 10 beats per minute
during each of the 10 sauna exposures, but quickly returned to pre sauna values after
exiting the sauna and remained this way for the 30 minute period under the thermal
blanket (Figure 2.3).
Markers of Health
Significant differences were observed for systolic and diastolic blood pressure
(systolic baseline 107.4 ± 13.9 mmHg, pre-sauna 99.2 ± 15.7 mmHg, and post-sauna 100
± 11.8 mmHg, p<.05); diastolic baseline 65.6 ± 5.8 mmHg, pre-sauna 60 ± 7.9 mmHg,
and post-sauna 60.8 ± 8.2 mmHg, p<0.05), (Table 2.4). No significant changes were
observed for resting heart rate, body mass, body fat percentage, total cholesterol, high
density lipoproteins, triglycerides, low density lipoproteins, non-high density
lipoproteins, or blood glucose (Table 2.4). Hematocrit was significantly increased
following 10 days of sauna treatment (baseline 41.0 ± 5.0, pre-sauna 41.6 ± 4.6, and postsauna 43.0 ± 4.6, p=0.006) (Table 2.4).
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Table 2.3. Mean sessional tympanic temperatures.

Participant
1
2
3
4
5
Mean

Pre-Sauna
36.6
35.7
36.5
35.0
37.1
36.0

±
±
±
±
±
±

0.4
0.5
0.3
0.5
0.3
0.8

Tympanic Temperature (oC)
Post Sauna
Post Session
38.1
37.8
38.5
37.0
38.3
37.9

±
±
±
±
±
±

0.5
0.4
0.4
0.5
0.6
0.6

37.1
36.8
36.8
36.4
37.4
36.9

±
±
±
±
±
±

0.1
0.3
0.4
0.2
0.3
0.4

Average 10 day tympanic temperatures for each participant (n=5). Pre-sauna= prior to
entering sauna, post-sauna= upon exiting sauna, post session= following 30 minute
covered rest.
(* p<0.001)
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Figure 2.2

Figure 2.2. Tympanic temperature during sauna exposure and rest (n=5). *p<0.001
between pre- and post-sauna temperature. Each data point represents the mean ±
standard deviation. † = p <0.05 compared to pre-sauna temperature. p = 0.051 at 30
minutes compared to pre-sauna.
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Figure 2.3
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Figure 2.3. Average 10-day
day heart rate response at rest, immediately following sauna bath,
and during covered rest (n=5)
(n=5). Each data point represents mean ± standard deviation. No
significant differences (p=0.056).
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Table 2.4. Physiological measures of participants at baseline, prior to sauna treatment
(pre-sauna), and following 2 weeks of sauna treatment (n=5).

Measure
SBP (mmHg)
DBP (mmHg)
Resting HR
Body mass (kg)
Body fat (%)
Total Cholesterol (mg/dL)
HDL (mmHg)
Triglycerides (mg/dL)
LDL (mmHg)
non-HDL (mg/dL)
Glucose (mg/dL)
Hematocrit (%)

Baseline

Pre-Sauna

Post-Sauna

p

107.4 ± 13.9
65.6 ± 5.8
67.6 ± 7.0
73.8 ± 10.9
28.6 ± 9.6
185.6 ± 81.3
68.2 ± 17.5
118 ± 70.4
133.8 ± 35.6
157.2 ± 47.9
83.4 ± 7.4
41.0 ± 5.0

99.2 ± 15.7 †
60.0 ± 7.9 †
65.6 ± 4.0
74.5 ± 10.5
29.4 ± 9.6
228.0 ± 49.9
67.0 ± 22.6
109.0 ± 37.4
136.5 ± 49.0
160.3 ± 54.5
82.2 ± 11.0
41.6 ± 1.91

100.0 ± 11.8
60.8 ± 8.2
62.4 ± 4.6
74.3 ± 10.8
29.3 ± 9.9
213.0 ± 49.1
62.8 ± 11.1
100.6 ± 29.8
130.0 ± 46.5
150.0 ± 51.9
81.4 ± 9.9
43.0 ± 4.6*

0.028
0.027
0.404
0.627
0.732
0.480
0.903
0.740
0.877
0.820
0.903
0.006

Data are presented as means and standard deviations. *=significantly different from
baseline and pre-sauna therapy, p<0.05. †= significantly different from baseline, p<0.05.
SBP (systolic blood pressure), DBP (diastolic blood pressure), HDL (high density
lipoprotein), LDL (low density lipoprotein), non-HDL (non-high density lipoprotein).
Reference values (mg/dL):
Total cholesterol: desirable (<200), borderline high (200-239), high (≥240)
HDL: low (<40), high (≥60)
LDL: optimal (<100), borderline high (130-159), high (160-189)
Triglycerides: normal (<150), borderline high (150-199), high (200-499)
Fasting plasma glucose: normal (<100)
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Heart Rate Variability
Heart rate variability (HRV) data was not available for only one male participant
due to an unforeseen technical malfunction. Nonetheless, there were no significant
differences observed for any component of HRV (Table 2.5).
Psychological Measures
The State-Trait Anxiety Inventory (STAI) was completed at baseline, 2 weeks
later, and upon completion of 2 weeks of sauna exposure. There were no significant
differences for state or trait anxiety scores across trials (Table 2.6).
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Table 2.5. Heart rate variability measures for participants (n=5), before sauna treatment
(pre-sauna) and following 2 weeks of sauna treatment (post-sauna).

Measure
Mean
SD
VLF
LF
HF
Total
Power
LF:HF
HF:TP

sex
ID
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna
pre-sauna
post-sauna

f
1

Participant
f
f
2
3

1003
963.3
935.6
927.2
73.62
127.2
67.83
61.72
1142.79
574.8
1136.35 729.69
1409.94 740.94
1015.19 791.59
294.39 127.34
324.09
81
3264.6 1443.09
2475.63 3755.63
4.79
5.82
3.13
9.77
0.1
0.09
0.13
0.02

889.8
1062
58.71
80.3
712.81
1098.09
427.08
1842.61
484.26
480.18
1624.15
3420.88
0.88
3.84
0.3
0.14

m
4

Mean ± SD

942.3
949.6 ± 47.1
757
920.5 ± 125.2
46.58
76.53 ± 35.55
29.88
59.93 ± 21.48
349.85 695.06 ± 333.87
163.9 782.01 ± 451.02
429.72 751.92 ± 462.76
259.34 977.18 ± 658.32
95.61
250.4 ± 178.63
23.34 227.15 ± 213.17
875.18 1801.76 ± 1026.1
446.57 2524.68 ± 1487.66
4.49
4 ± 2.15
11.11
6.96 ± 4.06
0.11
0.15 ± 0.1
0.05
0.09 ± 0.06

p

0.721
0.429
0.526
0.619
0.379
0.422
0.184
0.193

Data are presented as means for each participant. Data are unavailable for 1 male
participant due to unforeseen technical errors. Means ± standard deviations are presented
for the group. There were no significant differences in any of the HRV measures. Pvalues represent pre versus post for each measure. SD (standard deviation of NN
intervals), VLF (very low frequency), LF (low frequency), HF (high frequency), LF:HF
(low frequency to high frequency ratio), HF:TP (high frequency to total power ratio).
Normal values (Mahk, 1991):
Total power (ms2): 3466 ± 1018
Low frequency power (ms2): 1170 ± 416
High frequency power (ms2): 975 ± 206
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Table 2.6. State and trait anxiety measures for participants at baseline, prior to sauna
treatment (pre-sauna), and following two weeks of sauna treatment (post-sauna). (n=5).
Measure
State
Trait

Baseline

Pre-Sauna

Post-Sauna

49.8 ± 4.60
47.4 ± 3.58

49.6 ± 2.30
46.2 ± 1.64

49.8 ± 1.79
45.6 ± 2.30

p
0.994
0.396

Data are presented as means ± standard deviations. There were no significant differences
between any time points.
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Acute Vs. Chronic Effects of Sauna Bathing
In order to determine whether there were differences between a young healthy
population and repeated exposures of a middle-aged population, a separate group of
participants was recruited and subjected to only 1 sauna session as described in the
methods. 5 male subjects (aged 19.89 ± 2.1 years) agreed to participate before closure of
the St. Denis Centre sauna. The heart rate response to passive heating did not differ
between the young or middle aged groups (Figure 2.4), however the middle-aged group
showed greater tympanic temperature elevations (p<0.05; Figure 2.5).
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Figure 2.4
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Figure 2.4. Average heart rate during a single sauna bath
ath and covered rest among 18-29
18
year old participants (n=5), and the 10 day average heart rate during sauna bath and
covered rest among 30-55
55 year old participants (n=5).. Each data point represents the
mean ± standard deviation. There were no significant differences between groups
(p=0.515).
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Figure 2.5
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Figure 2.5. Average tympanic
ympanic temperature during a single sauna bath and covered rest
among 18-29
29 year old participants (n=5), and the 10 day average tympanic temperature
during sauna bath and covered rest among 30
30-55
55 year old participants (n=5). Each data
point represents the mean ± standard deviation. There was a significant main effect for
age such that the 30-55
55 year old participants exhibited significantly higher tympanic
temperature in response to sauna exposure (p<0.05).
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2.5 Discussion/Conclusions
Since increasing age is associated with the development of cardiovascular risk
factors and an increased risk of adverse events and CVD, we utilized a sauna bathing
intervention similar to that of Kihara et al (2004) to determine whether sauna treatment
could improve various health markers. Each sauna session elevated core temperature by
approximately 1.5oC and then maintained an approximately 1oC increase above pre-sauna
values throughout the 15 minute sauna period and the 30 minute covered rest. Further,
HR was elevated by approximately 10 bpm immediately following each sauna bout. As
such, we predicted training effects following a 2 week intervention, however, heart rate
variability (HRV) and other health markers did not show improvements following 2
weeks of sauna use. Subsequent to secondary analysis, we noted that middle-aged
participants attained greater tympanic temperatures compared to young participants,
which would be indicative of a greater heat stress. Nonetheless, factors such as sample
size, and the degree of heat stress may have accounted for the lack of significant
improvements in these health markers.
The primary measure of this study was heart rate variability. We anticipated
improvements in HRV following 2 weeks of sauna use, however we observed no
significant differences between pre- and post- treatment measures. The small sample size
may account for the lack of statistical significance, and may be of particular importance
with respect to female participants as HRV is influenced by menstrual cycle phase (Sato
et al., 1995). Specifically, HF power tends to decrease during the luteal phase, while the

LF:HF ratio increases. We attempted to account for these changes by documenting the
approximate last menstrual cycle start date at the onset of the study. Based on the self81

report, we determined testing occurred during the follicular phase for one participant, the
luteal phase for another, and was unknown for the third, as she experienced amenorrhea
within the recent months leading up to the study. Despite taking this information into
account, our results did not follow the trends proposed by Sato et al (1995). It is possible
that participants provided inaccurate reports of menstrual cycle start date. However, the
male participant and the amenorrheic female participant also showed no improvement in
the HRV measures, suggesting menstrual cycle phase may not be the sole factor
influencing HRV.
The time of measurement may also account for the differences between our
results and those reported by Kihara et al (2004). Participants underwent final
physiological and psychological testing, including ECG recording between 2 and 3 days
following the final sauna treatment. Kihara et al (2004) performed ECG recording the
day after the final treatment. Consequently, it is possible that the ECG improvements are
transient and that the brief period (2 weeks) of sauna exposure is not able to provide
lasting adaptations. Moreover, another possible difference between the data reported by
Kihara et al (2004) and those of the present study may have been in the length of time of
HRV collection. In the present study, a short-term measure of HRV was performed
under standard laboratory conditions. Kihara et al (2004) analyzed a minimum of 18
hours of data from 24 hour recordings the day after sauna treatment. Differences between
these methods have been suggested, and with short-term recordings, HRV has been
shown to return to baseline shortly after transient perturbations such as mild exercise
(Camm et al, 1996). Furthermore, some research indicates 24-hour recordings are stable
and ideal to assess intervention therapies (Camm et al., 1996). As such, it is possible that
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the rest period between completion of sauna treatment and the final ECG acquisition,
coupled with the short-term recording may account for the different findings in this study.
It is important to note, however, that transient changes in some physiological measure can
last for a day after perturbation. As such, it was necessary in the present study to perform
final testing after a 48 hour “wash-out” period to ensure we could be observing
adaptations and not transient responses.
Lastly, unlike previous research into the effects of sauna therapy (Kihara et al.,
2002; Kihara et al., 2004; Imamura et al., 2001), we used a dry sauna instead of a farinfrared sauna due to availability and it is difficult to determine whether we achieved a
similar degree of heat stress since core temperature changes during and after sauna
exposure were not reported in that study. In the present study, sauna exposure was
sufficient to elevate heart rate to between 92 and 103 beats per minute. The maximal
heart rate values obtained during the VO2peak test ranged from 159 to 189 beats per
minute. Thus, passive heating resulted in a heart rate response similar to that of low
intensity exercise. Given that our population was in good general health, it is possible
that the stress of sauna bathing was not sufficient to influence HRV.
The degree of heat stress may also interact with the renin-angiotensin-aldosterone
system (RAAS) to influence HRV. In CHF, poor perfusion to the kidneys stimulates
renin release (Nicholls, Robertson, & Inagami, 2001; Zablocki & Sadoshima, 2010).
ANGII (a hormone that promotes blood vessel constriction), which is produced through
the conversion of renin, is involved in the cardiac remodeling that occurs in CHF, as
TGF-β, a protein associated with structural remodeling, is a downstream target of ANGII
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(Huntgeburth et al., 2011). Furthermore, ANGII inhibits vagal activity (Townend et al.,
1995). Athletes tend to have greater vagal activity as a result of lower plasma renin,
therefore less ANGII inhibition (Fagard et al., 1985). Since low blood pressure
stimulates the secretion of renin seen in CHF, it is possible that physiological stressors
such as passive heating that increase blood pressure may reduce this renin secretion and
ultimately reduce vagal suppression by ANGII. Since our sample population was
generally healthy, we suspect the blood pressure increases during sauna exposure did not
reduce renin secretion and ANGII inhibition of vagal activity, as participants did not have
the excessive renin secretion associated with CHF. Further, we used a 2-week
intervention similar to what Kihara et al (2004) implemented for CHF patients. Again,
considering our population was free of CVD, the duration of the sauna exposure may
have been too short. In an animal study, for example, Ikeda et al (2001) reported
temperature increases similar to the present study, however the intervention was 4 weeks
in duration.
Based on the current literature, we predicted declines in resting systolic and
diastolic blood pressure (Imamura et al., 2001; Kihara et al., 2002). As with the HRV
measure, sample size and the timing of the final physiological testing session may
account for the differences in our results. Further, Kihara et al (2002) and Imamura et al
(2001) examined the effects of sauna treatment in New York Heart Association Class II
and III CHF patients. These individuals have a limited ability to participate in regular
physical activity, as fatigue and dyspnea often occur. Passive heating may replace
exercise for these individuals as it provides a mild cardiovascular stress with minimal
risk. Our population were middle-aged, without cardiovascular or metabolic disease and
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were able to safely perform a maximal exercise test. Our participants also ranged from
low to moderately recreationally active. Therefore, they likely accumulated more
physical activity per week than those in previous studies. Given that exercise produces
shear stress on the vasculature, it is possible that the shear forces generated during the
daily sauna exposure were comparable to, or even milder than what occurred during
exercise. In support of this, one may compare maximal heart rate during the VO2peak test
to the heart rate response during sauna exposure. Maximal values ranged from 159 to
189 beats per minute, while sauna bathing resulted in maximal values between 92 and
103 beats per minute. Cardiac output, as a function of heart rate and stroke volume,
many not have been sufficiently increased to generate larger shearing forces on the
vasculature. Therefore, the shear forces may have been insufficient to influence NO
activity.
The timing of the final measurement may have been a factor in the blood pressure
results as well. Kihara et al (2002) measured blood pressure one day following cessation
of sauna treatment. Our final testing occurred between 48-72 hours following the final
sauna exposure, in order to eliminate the acute effects of sauna use. A single moderate
intensity aerobic exercise session is sufficient to influence 24-hour ambulatory blood
pressure (Ciolac et al., 2008; Forjaz et al., 2000). Given the similar cardiovascular
response to exercise and passive heating, it was possible that blood pressure may have
been altered within 24 hours of sauna exposure. Despite this, it is possible that sauna
bathing has no effect on resting blood pressure. In line with our findings, Kihara et al
(2004) found no significant differences in resting blood pressure following 2 weeks of
sauna treatment, despite measuring blood pressure one day after the final sauna bout.
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While exercise and passive heating elicit similar cardiovascular responses, the
immediate post-exercise increase followed by a delayed reduction in blood glucose is
primarily mediated by working skeletal muscle. Passive heating is not accompanied by
large increase in skeletal muscle substrate demands, however, increased blood flow to
skeletal muscle has been suggested to underlie improvements in fasting plasma glucose
and insulin sensitivity among diabetics following regular hot tub exposure (Ciolac et al.,
2008; Hooper, 1999). Both local and whole body heat stress are associated with
increases in skeletal muscle blood flow (Heinonen et al., 2011; Pearson et al., 2011). As
such, a single sauna bath may not be sufficient to influence fasting blood glucose (this
was indicated in the separate group of young subjects; data not shown), however,
improvements may occur with repeated passive heating. Following our 2-week sauna
intervention, blood glucose levels remained unchanged or slightly elevated among 4 of
the 5 participants. Interestingly, the participant with the highest baseline blood glucose
level showed a 15 mg/dL reduction following sauna treatment. Imamura et al (2001) and
Hooper (1999) found improved fasting plasma glucose and insulin sensitivity among
patients with at least 1 coronary risk factor and Type II Diabetics. It may be that sauna
treatment is an effective glucose lowering therapy for diabetics or non-diabetics with
elevated blood glucose as opposed to those with low-normal blood glucose.
No changes were observed for high density lipoproteins (HDL), low density
lipoproteins (LDL), total cholesterol (TC), or triglycerides (TRG). It is likely that the
duration of sauna exposure and the degree of cardiovascular strain account for these
findings. HDLs are typically increased with regular exercise. In endurance trained
individuals, increased lipid transfer to HDLs and decreased HDL clearance by hepatic
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lipase contribute to a greater HDL apoA-I half-life and cholesterol excretion (Kraus &
Slentz, 2009; Rashid & Genest, 2007). The duration of exercise, supported by the
findings in endurance trained individuals, has been suggested as the most important
element of training for HDL increase (Kodama et al., 2007). As such, the 15-minute
sauna bath, while sufficient to elicit a response similar to exercise, may not have been of
sufficient duration to influence HDL concentrations. Furthermore, LDLs are generally
not responsive to exercise (Kraus & Slentz, 2009), and we did not anticipate significant
improvements following sauna bathing. Since HDL and LDL concentrations remained
unchanged, TC and the LDL:HDL ratio were also unchanged.
Hematocrit levels increased among all participants following 2 weeks of sauna
exposure. Generally, exercise-induced hypoxia stimulates erythropoiesis (Smith, Bleyer,
Little, & Sane, 2003) by increasing erythropoietin release from the kidneys. As sauna
bathing is a form of passive heating, oxygen extraction in skeletal muscle does not create
the hypoxic condition required to stimulate erythropoiesis. It has been shown, however,
that oxygen extraction by essential organs such as the brain is increased during passive
heating (Fan et al., 2008; González-Alonso et al., 2004) . In order to counter the effects
of passive heating, skin blood flow increases to aid in evaporative cooling while blood
flow to essential organs is maintained, resulting in greater cardiovascular strain. These
effects, coupled with greater oxygen extraction by the brain and other essential organs
may have stimulated erythropoiesis in a similar manner as exercise stress.
Plasma volume increases with endurance training, as the result of greater
aldosterone action (Convertino, 1991). Interestingly, during exhaustive exercise in heat,
87

aldosterone exhibits a temperature-dependent increase up to 38.5°C (Wright, Selkirk, &
McLellan, 2010). Therefore aldosterone would be expected to increase as a result of
sauna exposure, as average tympanic temperature was 37.9°C. Despite this, we observed
a decrease in plasma volume, which may be due to the cardiorespiratory fitness of our
population. Wright et al (2010) noted that aldosterone was significantly higher in trained
(VO2peak = 70 ± 2 ml/kg/min-1) compared to untrained (VO2peak = 50 ± 1 ml/kg/min-1)
individuals. The average VO2peak of our participants was 20.76 ± 7.42 ml/kg/min-1. The
sauna treatment was the equivalent of low-intensity exercise, and lasted only 15 minutes.
As such, this stress was insufficient to improve aerobic fitness and increase aldosterone
action. Further, hydration status at the time of measurement may have contributed to
these results.
Lastly, despite being instructed not to make any changes to physical activity
levels for the duration of the study, participants may have reduced exercise due to time
constraints. Participation in the study required approximately 45 minutes, five times per
week. Since participants had family and work responsibilities, the sauna session may
have replaced some of the time set allotted for exercise. While we suspect the stress of
passive heating is similar to exercise stress, heat stress may have been less intense and
shorter duration than regular aerobic exercise sessions. Therefore, the possibility of
detraining resulting in lower plasma volume and greater hematocrit should be considered.
It is likely that body weight and body fat percentage did not change due to the fact
that our sample population was between normal and overweight (mean BMI 25.66 ±
1.21), not obese. Reductions in body weight and body fat have been reported following
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similar sauna treatments, however, participants were obese (Biro, Masuda, Kihara, & Tei,
2003). When normal weight individuals underwent the same treatment, increased plasma
ghrelin accompanied appetite increases (Biro et al., 2003). As participants did not report
appetite loss or reduction prior to the onset of the study, plasma ghrelin was likely within
normal ranges. Further, the weight loss among obese patients was not accompanied by
increased plasma ghrelin. It is suggested that obese individuals have a reduced ghrelin
sensitivity, or maximal suppression of ghrelin secretion preventing a response following
sauna treatment (Biro et al., 2003) and indicating the need for further studies examining
the mechanisms of sauna use and weight loss. Therefore, since our sample population
was normal weight to overweight and did not report appetite abnormalities prior to sauna
treatment, plasma ghrelin changes may not have occurred, and weight remained
unchanged. Dietary changes must also be considered, as the study relied on self-report.
Unlike Hayasaka et al (2008) we found no differences in anxiety scores (state and
trait) following 2 weeks of sauna use. The timing of measurement may account for this
discrepancy, as Hayasaka et al (2008) measured anxiety before and after a single session
of passive heating while we measured anxiety 48-72 hours following the final sauna bath
of 2 weeks of sauna therapy. Exercise training has been shown to reduce state and trait
anxiety in a healthy middle aged population (Blumenthal, Williams, Needels, & Wallace,
1982), and given the similarities between exercise and heat stress we predicted
improvements in STAI scores. However, the intensity of physiological stress may have
been too mild during the sauna exposure, as Blumenthal et al (1982) employed an
exercise intervention at 70-85% of VO2peak. The mechanisms underlying anxiety
reductions following exercise include increases in serotonin, central norepinephrine
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transmission and a greater concentration of endorphins (Helmich et al., 2010). βendorphins increase at approximately 80% V02peak (McMurray, Forsythe, Mar, & Hardy,
1987), therefore the intensity of heat stress in the present study may have been too mild to
influence endorphin release and psychological outcomes.
In conclusion, acute sauna exposure elicits a physiological stress response similar
to that observed with low intensity exercise. However, 2 weeks of daily sauna use with a
concomitant tympanic temperature increase of 1-1.5°C was not associated with
improvements in markers of cardiovascular, metabolic and psychological health. Given
the results of previous research, it is likely that this mode and duration of therapy is
sufficient to improve the health of diseased individuals, but does not appear to make
impact already healthy middle-aged adults.

2.6 Limitations and Future Directions
Kihara et al (2002) recruited CHF patients for a 2-week sauna therapy
intervention. We recruited relatively healthy middle-aged adults, but were unable to
successfully obtain enough participants to satisfy power requirements. We aimed to
recruit 20-25 participants based on sample size calculations with a small-moderate effect
size at an alpha level of 0.05, and a power of 0.80. This was based on the data of Kihara
et al (2004) who reported large effect sizes for HRV measures. Unfortunately, participant
interest in the study was never strong and of those who were interested, several did not
meet inclusion/exclusion criteria. As a further hindrance to our recruitment efforts, the
saunas at the University of Windsor were opened only for males and then closed due to
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unforeseen circumstances partly through the study. Because the power was so small,
definitive conclusions could not be made with this dataset. However, in the small sample
size in which data was collected, sauna therapy appeared to have no effect on markers of
cardiovascular or psychological health.
Secondly, previous studies used far-infrared saunas and reported only that the
saunas were maintained at 60°C temperature (Imamura et al., 2001; Kihara et al., 2002,
2004, 2009). In the present study, dry saunas were used which were located in fitness
centres, resulting in inconsistent temperatures as the general public were able to access
the sauna during testing, allowing warm air to exit periodically throughout sauna bathing.
Although this field study may have resulted in a milder heat stress compared to a
laboratory setting, these observations would be what the general public would experience
if attending either of the fitness facilities incorporated in this study. If the health benefits
of sauna treatment are going to be purported by fitness centres, it is imperative that the
knowledge of the therapeutic parameters of a sauna be conveyed to its staff and members.
Moreover, future studies should examine the effects of greater heat stress or a longer
duration sauna exposure, either as a longer bout of passive heating or more long-term use.
Greater heat stress may be associated with improvements in health markers.
Participants were also instructed not to alter their diet or exercise habits for the
duration of the study, however it is possible that this was difficult to maintain, as a
portion of the study occurred during the winter holidays when routines may have been
difficult to uphold. Dietary and activity records were not kept during this period and it is
possible that this had an effect on the ability to detect physiological changes.
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Finally, in an effort to account for HRV fluctuations during the menstrual cycle
(Bai et al., 2009; Baker et al., 2008), baseline values from the initial visit were compared
to post-sauna values. However, one participant experienced amenorrhea in the months
leading up to the study. The amenorrhea was a menstrual cycle irregularity, however the
participant was not considered fully menopausal. Thus, pre-sauna and post-treatment
values were compared. Nonetheless, while it is likely that the length of time between
initial and post sauna testing would have put the female individuals in the same phase of
the menstrual cycle, this is unknown. However, given that there were no significant
differences observed in any measure of HRV suggest that even if there were changes,
these would not be profound adaptations because menstrual cycle could override them.
Work in this area needs further investigation.
Despite these limitations, the outcomes of this study could provide insight into
novel strategies to prevent the onset of cardiovascular and metabolic disease. Passive
heating was able to significantly alter the physiology (temperature and HR) of healthy
young and middle-aged adults. However, the physiological stresses of 2 weeks of 15 min
sauna baths may not be great enough to elicit lasting adaptations. Future studies should
examine greater increases in core temperature and/or greater durations of heat
acclimation in these populations in order to determine their therapeutic use. Currently,
adherence rates to traditional physical activity programs are low. Thus, the development
of new strategies requiring minimal effort and time commitment may improve adherence
and improve health markers in the middle-aged population, ultimately reducing the
incidence of cardiovascular and metabolic disease-related deaths.
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Appendix A: Physical Activity Readiness Questionnaire (PAR-Q)
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Appendix B: Participant Information Sheet
Name: ______________________________

D.O.B. (dd/mm/yy) ____/____/____

Sex: m_____ f _____ prefer not to disclose _____

Last start date of menstrual cycle (females only): ______________________________

Contact information:

Phone: (

) _________-______________________

E-mail: ____________________________@________________________

Emergency contact (optional)

Name: ___________________________

Phone: (

) _________-______________________
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Appendix C: Medications/Medical Conditions
Are you experiencing or have you experienced any of the following conditions (check all
that apply):

•

Aortic stenosis (valvular heart disease) [ ]

•

Unstable angina pectors [ ]

•

Myocardial infarction [ ]

•

Heart failure [ ]

•

Cardiac arrhythmia [ ]

•

Hypertension [ ]

•

Hypotension [ ]

•

Orthopedic conditions (ie. joint pain, limited mobility) [ ]

•

Are you currently pregnant? [ ]

•

Do you have any of the following cardiovascular disease risk factors?
o Family history of heart disease [ ]
o Smoking [ ]
o Sedentary lifestyle (less than 30 min of moderate intensity exercise 3 days
per week) [ ]
o Obesity [ ]
o Hypertension (blood pressure greater than 140mmHg/90mmHg, or
diagnosed by a physician) [ ]
o Dyslipidemia [ ]
o Diabetes or prediabetes [ ]
104

•

Are you taking any of the following medications?
o Diuretics (used to treat high blood pressure)
o Anticholinergics (ie. Cogentin, Atropine, Atrovent, Spiriva, Elavil,
Tofranil, and Anafranil)
o Barbiturates (ie. Seconal, Nembutal, Amytal, and Tuinal)
o Beta blockers (ie. Sectral, Tenormin, Kerlone, Lopressor, etc)
o Antihistamines

[ ] Yes, I am currently taking one or more of these medications.
[ ] No, I am not taking any of these medications.

Name: ____________________________________
Date (dd/mm/yy) _____/_____/_____

Signature:__________________________________
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Appendix D: State Trait Anxiety Inventory (STAI)

Due to the terms of use of the STAI (see next page), a sample of only 5 questions may be
used in this document.

Sample Items

I feel calm............................................................................................................................1
2 3 4

I am tense.............................................................................................................................1
2 3 4

I feel self confident..............................................................................................................1
2 3 4

I feel nervous........................................................................................................................1
2 3 4

I am relaxed..........................................................................................................................1
2 3 4
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